In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal title
Antimicrobial agents and chemotherapyDate Published
2019-07-25Publication Volume
63Publication Issue
8
Metadata
Show full item recordCitation
Kohlhoff S, Huerta N, Hammerschlag MR. In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e01048-19. doi: 10.1128/AAC.01048-19. PMID: 31160287; PMCID: PMC6658800.DOI
10.1128/AAC.01048-19ae974a485f413a2113503eed53cd6c53
10.1128/AAC.01048-19
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- Comparative in vitro activity of garenoxacin against Chlamydia spp.
- Authors: Donati M, Pollini GM, Sparacino M, Fortugno MT, Laghi E, Cevenini R
- Issue date: 2002 Sep
- In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.
- Authors: Pereyre S, de Barbeyrac B, Renaudin H, Poutiers F, Bébéar C, Bébéar CM
- Issue date: 2001 Feb
- The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.
- Authors: Hammerschlag MR, Roblin PM
- Issue date: 2004 Jul
- Activity of quinolones against Chlamydia pneumoniae.
- Authors: Hammerschlag MR
- Issue date: 1999
- Potential for antimicrobial resistance in Chlamydia pneumoniae.
- Authors: Stamm WE
- Issue date: 2000 Jun